vs
Side-by-side financial comparison of STEPAN CO (SCL) and TOWER SEMICONDUCTOR LTD (TSEM). Click either name above to swap in a different company.
STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $351.2M, roughly 1.7× TOWER SEMICONDUCTOR LTD). TOWER SEMICONDUCTOR LTD runs the higher net margin — 15.2% vs 3.3%, a 12.0% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -1.7%).
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
Tower Semiconductor Ltd. is an Israeli company that manufactures integrated circuits using specialty process technologies, including SiGe, BiCMOS, Silicon Photonics, SOI, mixed-signal and RFCMOS, CMOS image sensors, non-imaging sensors, power management (BCD), and non-volatile memory (NVM) as well as MEMS capabilities. Tower Semiconductor also owns 51% of TPSCo, an enterprise with Nuvoton Technology Corporation Japan (NTCJ).
SCL vs TSEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $604.5M | $351.2M |
| Net Profit | $19.7M | $53.4M |
| Gross Margin | 10.7% | 24.8% |
| Operating Margin | 4.7% | 15.7% |
| Net Margin | 3.3% | 15.2% |
| Revenue YoY | 1.9% | -1.7% |
| Net Profit YoY | — | 4.4% |
| EPS (diluted) | $0.86 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $604.5M | — | ||
| Q4 25 | $553.9M | — | ||
| Q3 25 | $590.3M | — | ||
| Q2 25 | $594.7M | — | ||
| Q1 25 | $593.3M | — | ||
| Q4 24 | $525.6M | — | ||
| Q3 24 | $546.8M | — | ||
| Q2 24 | $556.4M | $351.2M |
| Q1 26 | $19.7M | — | ||
| Q4 25 | $5.0M | — | ||
| Q3 25 | $10.8M | — | ||
| Q2 25 | $11.3M | — | ||
| Q1 25 | $19.7M | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $23.6M | — | ||
| Q2 24 | $9.5M | $53.4M |
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.3% | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | 12.1% | — | ||
| Q1 25 | 12.7% | — | ||
| Q4 24 | 10.8% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 12.5% | 24.8% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 3.4% | 15.7% |
| Q1 26 | 3.3% | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 1.7% | 15.2% |
| Q1 26 | $0.86 | — | ||
| Q4 25 | $0.22 | — | ||
| Q3 25 | $0.47 | — | ||
| Q2 25 | $0.50 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.14 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.42 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $265.3M |
| Total DebtLower is stronger | $328.4M | — |
| Stockholders' EquityBook value | $1.2B | $2.5B |
| Total Assets | $2.3B | $3.0B |
| Debt / EquityLower = less leverage | 0.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $132.7M | — | ||
| Q3 25 | $118.5M | — | ||
| Q2 25 | $88.9M | — | ||
| Q1 25 | $107.5M | — | ||
| Q4 24 | $99.7M | — | ||
| Q3 24 | $147.3M | — | ||
| Q2 24 | $124.7M | $265.3M |
| Q1 26 | $328.4M | — | ||
| Q4 25 | $626.7M | — | ||
| Q3 25 | $655.5M | — | ||
| Q2 25 | $658.0M | — | ||
| Q1 25 | $659.3M | — | ||
| Q4 24 | $625.4M | — | ||
| Q3 24 | $688.5M | — | ||
| Q2 24 | $657.1M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | $2.5B |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.3B | $3.0B |
| Q1 26 | 0.28× | — | ||
| Q4 25 | 0.50× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.53× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | 0.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
TSEM
Segment breakdown not available.
